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Abstract
 Rationale—Short-term effects of air pollution exposure on respiratory disease mortality are 
well established. However, few studies have examined the effects of long-term exposure, and 
among those that have, results are inconsistent.
 Objectives—To evaluate long-term association between ambient ozone, fine particulate matter 
(PM2.5, particles with an aerodynamic diameter of 2.5 µm or less), and chronic lower respiratory 
disease (CLRD) mortality in the contiguous United States.
 Methods—We fit Bayesian hierarchical spatial Poisson models, adjusting for five county-level 
covariates (percentage of adults aged ≥65 years, poverty, lifetime smoking, obesity, and 
temperature), with random effects at state and county levels to account for spatial heterogeneity 
and spatial dependence.
 Measurements and Main Results—We derived county-level average daily concentration 
levels for ambient ozone and PM2.5 for 2001–2008 from the U.S. Environmental Protection 
Agency’s down-scaled estimates and obtained 2007–2008 CLRD deaths from the National Center 
for Health Statistics. Exposure to ambient ozone was associated with an increased rate of CLRD 
deaths, with a rate ratio of 1.05 (95% credible interval, 1.01–1.09) per 5-ppb increase in ozone; the 
association between ambient PM2.5 and CLRD mortality was positive but statistically insignificant 
(rate ratio, 1.07; 95% credible interval, 0.99–1.14).
 Conclusions—This study links air pollution exposure data with CLRD mortality for all 3,109 
contiguous U.S. counties. Ambient ozone may be associated with an increased rate of death from 
CLRD in the contiguous United States. Although we adjusted for selected county-level covariates 
and unobserved influences through Bayesian hierarchical spatial modeling, the possibility of 
ecologic bias remains.
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Short- and long-term exposure to ozone and PM2.5 (particles with an aerodynamic diameter 
of 2.5 µm or less) air pollution may contribute to an increased risk of the onset of disease, 
exacerbation of symptoms, and mortality (1). The short-term effects of ambient ozone and 
PM2.5 on respiratory disease mortality are well established (2–5). However, few studies have 
examined the effects of long-term exposure and, among those that have, results are 
inconsistent (6–11). Understanding the specific contribution of short-term (up to a few 
weeks) versus long-term (1 yr or more) exposure is complicated and is typically approached 
using different study designs (1). Unlike time-series studies, which examine deaths due to 
short-term exposure, cohort studies are used to evaluate deaths over a longer time period, 
reflecting cumulative effects of both short- and long-term exposure.
Using the American Cancer Society (ACS) cohort, Jerrett and colleagues found a significant 
association between long-term ozone exposure and respiratory disease mortality (8). In their 
more recent study of a California component of the ACS cohort, however, the association 
between ozone exposure and respiratory mortality was positive but insignificant (7). A 
multicity study of Medicare participants (mainly ≥65 yr) did find a positive association 
between long-term exposure to ozone and an increased risk of respiratory disease death—
particularly in those with chronic obstructive pulmonary disease (COPD), diabetes, 
congestive heart failure, and myocardial infarction (11). Results from studies evaluating the 
association between long-term exposure to PM2.5 and respiratory disease mortality have 
suggested no association or positive but insignificant association (9, 10).
Deaths from chronic lower respiratory disease (CLRD), which includes mainly asthma and 
COPD (emphysema and chronic bronchitis), account for 50% of all respiratory disease 
mortality and is the third leading cause of death in the United States (12). Although short-
term studies suggest a linkage between air pollution and CLRD morbidity and mortality 
(13), the effects of long-term air pollution on CLRD mortality remain uncertain. Previous 
studies focus on specific segments of population (e.g., aged ≥65 yr) or individuals willing to 
participate in prospective cohort studies (e.g., the ACS cohort). However, these studies are 
limited to metropolitan areas, and no national study exists. The U.S. National Environmental 
Public Health Tracking Network (Tracking Network) is a nationwide surveillance system 
that contains environmental and health data at state and county levels (14). In this study, 
county-level data were used to examine the association between long-term exposure to 
ozone and PM2.5 and CLRD mortality. We restricted our study to 48 states and the District 
of Columbia (3,109 counties), because modeled estimates of ozone and PM2.5 concentration 
were not available in the noncontiguous states of Alaska and Hawaii. To minimize potential 
bias related to traditional ecologic analyses, we used Bayesian hierarchical spatial modeling 
to account for five known place-varying confounders and unobserved heterogeneity and 
spatial dependence (15).
Hao et al. Page 2














We included 265,223 deaths that occurred among adults 45 years of age or older during 
2007–2008 in the contiguous United States. Each death record had a U.S. county identifier 
in the restricted mortality data file, which allowed us to summarize death counts by county 
and to link them with other county-level data sources. CLRD deaths included those with 
underlying cause coded as J40–J47 (ICD-10 codes). We derived county-level average daily 
ozone and PM2.5 by aggregating 2001–2008 census-tract-level 8-hour maximum ozone and 
24-hour average PM2.5 concentration, generated by the U.S. Environmental Protection 
Agency for the Tracking Network based on monitored data and output from the Community 
Multi-scale Air Quality modeling system (16). County-level lifetime smoking prevalence 
(percentage of adults who were current or former smokers) and obesity prevalence 
(percentage of obese adults with body mass index [the ratio of height to weight] ≥30) were 
derived from the Behavioral Risk Factor Surveillance System (2007–2008) (17), using the 
method suggested by Zhang and colleagues (18). The county-level percentage of adults at 
least 65 years of age and poverty levels (percentage of adults below the federal poverty line) 
were obtained from 2007–2008 census data (19). Extremely hot days were defined as the 
average annual number of days with maximum temperature equal to or greater than 90 
degrees Fahrenheit (°F). County-level daily maximum temperatures during 2001–2008 were 
obtained from the Tracking Network, originally from the North American Land Data 
Assimilation System (14).
We fit Bayesian hierarchical spatial Poisson models using CLRD death counts as the 
outcome and county-level variables as predictors. Five models were explored with different 
random effect specifications: model 1, state unstructured random effects only; model 2, state 
unstructured and county unstructured random effects; model 3, state unstructured and county 
spatially structured random effects; model 4, state unstructured, county unstructured, and 
county spatially structured random effects; model 5, model 4 with a mixture parameter 
embedded between county unstructured and county spatially structured random effects. 
Epidemiologically, state unstructured random effects specify state-level contextual effects on 
mortality; county unstructured random effects specify county-level heterogeneous contextual 
effects whereas county spatially structured random effects capture possible spatial 
dependence (i.e., spatial autocorrelation between adjacent counties). The mixture parameter 
allows the balance of county-level heterogeneity and spatial dependence. Our log-link 
Poisson regression model is log[yi] = log[Ei] + α + Xiβ + STj[i] + ρiUi + (1 – ρi)Si, where yi 
is the number of deaths for county i (i = 1, …, 3,109), Ei is the population (≥45 yr), α is the 
intercept, Xi is the vector of seven predictors (X1,i, …, X7,i), β[1, …, 7] is the corresponding 
regression coefficient, STj[i] (j = 1, …, 49) is state unstructured random effects, Ui is county 
unstructured random effects, Si is county spatially structured random effects, and ρ is the 
mixture parameter (0 ≤ ρ ≤1). County spatially structured random effects are formulated as 
 (20), where , wij = 
1, if i, j are adjacent counties, otherwise wij = 0. The state unstructured and county 
unstructured random effects are formulated as  and 
. , and  are the variance parameters of STj[i], Si, and Ui. In full 
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Bayesian analyses, prior distribution must be specified for these three variance parameters. 
We assigned diffusive/noninformative gamma distributions for these three parameters, as 
suggested by Bernardinelli and colleagues (21). We implemented these five models in 
WinBUGS1.4.3 and used the deviance information criterion (DIC) to compare model fit (15, 
22).
 Results
Table 1 shows the mean, range, and quartiles of ozone, PM2.5, and five selected 
demographic, socioeconomic, behavioral, and meteorological characteristics. Ozone 
exposure ranged from 27.8 to 52.0 ppb (median, 41.2 ppb), PM2.5 exposure ranged from 4.8 
to 16.8 µg/m3 (median, 10.9 µg/m3), percentage of adults 65 years of age or older ranged 
from 3.1 to 39.6% (median, 15.1%), percentage of adults below the federal poverty line 
ranged from 2.7 to 49.5% (median, 12.4%), lifetime smoking prevalence ranged from 24.6 
to 68.9% (median, 51.5%), obesity prevalence ranged from 16.6 to 50.2% (median, 30.0%), 
and extremely hot days ranged from 0 to 197 (median, 46).
Table 2 shows that model 3 produced the lowest DIC. The difference between the DIC for 
this model (21,474.7) and the DICs for models 4 and 5 (21,475.1 and 21,479.1, respectively) 
is admittedly small (<5), indicating that any of them could be the best model for describing 
the data (22). Still, model 3, with state unstructured and county spatially structured random 
effects, is preferred because it contains fewer parameters (23). In contrast, the difference is 
substantial between the DICs for models 3, 4, and 5 (21,474.7, 21,475.1, and 21,479.1, 
respectively) and the DICs for models 1 and 2 (21,606.4 and 21,607.4, respectively) (>5). It 
is evident that county spatially structured random effects dominate spatial dependence 
between neighboring counties, reflecting the effects of unobserved, spatially structured 
covariates.
Bayesian inference is based on posterior means (analogous to means) and credible intervals 
(CIs, analogous to confidence intervals). Table 3 presents adjusted rate ratios (RRs) and 95% 
CIs from model 3 (the preferred model with state unstructured and county spatially 
structured random effects), measured per five-unit increment for all variables. All predictors 
were positively associated with CLRD deaths. Specifically, the RR was 1.05 (95% CI, 1.01–
1.09) per 5-ppb increase in ozone exposure.
Ozone and PM2.5 were associated with a 5% (per 5-ppb increase in average ozone) and a 7% 
(per 5-µg/m3 increase in average PM2.5) increase in CLRD mortality, respectively, although 
the association between PM2.5 and CLRD mortality was not statistically significant. 
Together, ozone and PM2.5 explained about 3% of the total variation in log RRs (Table 4). 
Table 4 also shows that all predictors combined explained about 35% of the total variation 
with lifetime smoking, age (adults aged ≥65 yr), and poverty explaining most, whereas other 
unobserved covariates at state (5%) and county (60%) levels explained about 65%.
 Discussion
Our principal finding is that after controlling for selected demographic, socioeconomic, 
behavioral, and environmental risk factors, and other spatially unstructured and structured 
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contextual influences, ozone is associated with increased CLRD mortality rates across U.S. 
counties. A few cohort studies have observed similar results for ozone, but they were limited 
in terms of demographic or geographical coverage (8, 11, 24). This nationwide study 
explored the linkage between county-level concentration levels and aggregated deaths across 
the contiguous United States. Our analyses differ fundamentally from traditional ecologic 
analyses in that we used Bayesian hierarchical spatial modeling. Bayesian modeling allows 
for direct control of known (i.e., percent adults aged ≥65 yr, lifetime smoking, poverty, 
obesity, and temperature) and unknown (unstructured and spatially structured) risk factors. 
These analyses showed that CLRD mortality was significantly associated with ozone 
exposure. Such correlation might reflect an amalgam of complex pathophysiological 
pathways through which ozone could induce or accelerate pulmonary inflammation leading 
to CLRD mortality (25, 26).
Our results for the long-term effects of ozone on CLRD mortality are generally consistent 
with the findings from the ACS cohort (448,850 participants in 86 U.S. metropolitan areas 
during 1977–2000) (8) and Medicare subpopulations (3,210,511 persons with COPD in 105 
U.S. cities during 1985–2006) (11). Our adjusted RR estimate of 1.05 per 5-ppb increase in 
ozone—which is equivalent to 1.10 per 10-ppb increment— is lower than the estimate from 
Medicare participants hospitalized with COPD (RR, 1.07 [95% CI, 1.05–1.10] per 5-ppb 
increment), but it is higher than that from the ACS cohort (RR, 1.04 [95% CI, 1.01–1.07] per 
10-ppb increment). The study of a California ACS cohort reported a positive albeit 
insignificant association (RR, 1.02 [95% CI, 0.90–1.15] per 10-ppb increment), which might 
be due to the small number of participants (n = 73,711). The difference in RR estimates 
could be due in part to the difference in participants or study areas included in these studies. 
Participants hospitalized with COPD in the Medicare study might have had higher risk of 
CLRD death due to ozone exposure than did people without preexisting COPD as well as 
the general U.S. population. Participants in the ACS study were mainly white with relatively 
high educational attainment (27). Thus, subjects in the ACS study might have been healthier, 
and have had lower risk of CLRD death due to ozone exposure, than the U.S. population 
generally.
We found a positive but statistically insignificant association between long-term PM2.5 
exposure and CLRD mortality, with an adjusted RR estimate of 1.07 (95% CI, 0.99–1.14) 
per 5-µg/m3 increase in PM2.5 exposure, which is equivalent to 1.14 per 10-µg/m3 
increment. The Harvard Six Cities cohort (8,096 white participants) and California ACS 
cohort (73,711 participants) resulted in similar findings, with adjusted RRs of 1.05 (95% CI, 
0.95–1.15) for the California cohort and 1.08 (95% CI, 0.79–1.49) for the Harvard Six Cities 
cohort for an increase of 10 µg/m3 in PM2.5 exposure (7, 9). A study of a large ACS cohort 
(448,850 participants) using a single-pollutant model reported a similar association (RR, 
1.03 [95% CI, 0.96–1.11]) but reported an inverse and insignificant association in a two-
pollutant model when ozone was included (RR, 0.93 [95% CI, 0.84–1.03]) (8). Further 
studies are needed to confirm the association between PM2.5 and CLRD mortality at both the 
individual and aggregated population levels.
The increased risk of death due to CLRD associated with ozone was small compared with 
the risk posed by lifetime smoking, older age (≥65 yr), and temperature. Nevertheless, the 
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positive association between air pollution and CLRD mortality persisted after controlling for 
known and unknown factors at county and state levels. The adjusted RR for ozone was close 
to that for poverty, a county-level socioeconomic indicator—although lifetime smoking and 
older age were two known leading contributors to the CLRD mortality variation. It is worth 
noting that county-level unknown, spatially correlated influences contributed more than half 
of the CLRD death variations across U.S. counties; these influences were not considered in 
most previous studies. Also, the inclusion of spatially correlated random components could 
potentially increase the precision of the RR estimate for the known risk factors in which we 
were interested.
This study has several limitations. First, our single ecological study could not make any 
causal inference. Although we adjusted for available county-level covariates and unobserved 
influences, the possibility of ecologic bias remains. Furthermore, including 8 years of 
exposure data could be one of the strengths; however, it could also be a limitation because 
people could move during this time period and disease latency could be longer than the years 
we included in this study. Similarly, we could not account for any seasonal variation in or 
trend of exposure during this time period. National annual average ozone and PM2.5 both 
showed downward trends from 1980 (for ozone) and 2000 (for PM2.5), but such trends are 
not smooth and do show year-to-year influences of weather conditions, which contribute to 
ozone and PM2.5 formation in the air (28, 29). We used 8-year (2001–2008) average ozone 
and PM2.5 as proxies for their long-term exposure estimates; however, using exposure 
averaged during the early years (2001–2002) did not meaningfully change county-level RR 
estimates (see Table E4 in the online supplement). In addition, we did not address the 
seasonality of CLRD deaths, ozone, and PM2.5 because of the small sample size of CLRD 
deaths by season at the county level. Ozone shows a clear seasonal pattern, and linking the 
seasonal timing of death might strengthen the association found, if the number of deaths by 
season at the county level were sufficient to allow us to do so. Finally, we could not evaluate 
the sensitivity of ICD-10 codes (J40–J47) for the diagnosis of CLRD. Potential 
misclassification of CLRD as an underlying cause of death might introduce additional 
uncertainties in our findings. Findings of this national study suggest that ozone and PM2.5 
might have contributed to increased CLRD mortality across U.S. counties, although residual 
confounding cannot be excluded. The association observed between long-term ozone 
exposure and CLRD mortality across U.S. counties is in line with findings from previous 
cohort studies, but this study expands the evidence to the U.S. population. The positive 
association between long-term PM2.5 exposure and CLRD mortality is consistent with 
findings from previous studies. This U.S. national study provides additional evidence that 
ambient air pollutants, particularly ozone, could be important contributing factors in CLRD 
mortality.
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At a Glance Commentary
Scientific Knowledge on the Subject
The short-term effects of ambient ozone and fine particulate matter (PM2.5, particles with 
an aerodynamic diameter of 2.5 µm or less) on respiratory disease mortality are well 
established. However, few studies have examined the effects of long-term exposure and, 
among those that have, results are inconsistent.
What This Study Adds to the Field
This nationwide study links air pollution exposure data of ambient ozone and PM2.5 with 
chronic lower respiratory disease mortality for 3,109 contiguous U.S. counties. Our 
findings suggest that long-term exposure to ambient ozone may be associated with an 
increased rate of death from chronic lower respiratory disease in the contiguous United 
States.
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Table 2
Comparison of Deviance Information Criterion for Models with Different Random Effect Specification
Model Random Effect Specification DIC
1 State unstructured random effects only 21,606.4
2 State unstructured and county unstructured random effects 21,607.4
3 State unstructured and county spatially structured random effects 21,474.7
4 State unstructured, county unstructured, and county spatially
  structured random effects
21,475.1
5 Model 4 with a mixture parameter 21,479.1
Definition of abbreviation: DIC = deviance information criterion.
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Table 3
Adjusted Rate Ratios of Predictors Associated with Chronic Lower Respiratory Disease Deaths Measured per 
Five-Unit Increment for All Variables
Variable Rate Ratio 95% CI
Adults aged ≥65 yr, % 1.09 1.07–1.11
Poverty, % 1.06 1.04–1.08
Lifetime smoking, % 1.13 1.10–1.15
Obesity, % 1.03 1.01–1.05
Extremely hot days (≥90°F) 1.01 1.00–1.01
Ozone, ppb 1.05 1.01–1.09
PM2.5, µg/m3 1.07 0.99–1.14
Definition of abbreviations: CI = credible interval; PM2.5 = particulate matter with an aerodynamic diameter of 2.5 µm or less.
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Table 4
Variation in Chronic Lower Respiratory Disease Death Rates as Explained by Predictors and Random Effects
Variable Mean 2.50% Median 97.50%
Adults aged ≥65 yr, % 7.8% 4.9% 7.7% 11.1%
Poverty, % 5.7% 3.1% 5.6% 8.8%
Lifetime smoking, % 14.6% 10.0% 14.5% 19.7%
Obesity, % 0.8% 0.0% 0.7% 2.3%
Extremely hot days (≥90°F) 3.0% 0.2% 2.6% 7.8%
Ozone, ppb 1.3% 0.0% 1.1% 3.6%
PM2.5, µg/m3 1.8% 0.0% 1.5% 5.8%
State random effects 4.9% 2.5% 4.7% 8.5%
County spatial random effects 60.1% 53.7% 60.2% 66.0%
Definition of abbreviation: PM2.5 = particulate matter with an aerodynamic diameter of 2.5 µm or less.
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